Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ACHV

Achieve Life Sciences Inc

Apr 10 • 04:00PM ET

3.49

+0.17 5.12 %

Healthcare • Biotechnology • Canada • NASD

Peers: ARWR GERN IMMP SGMO ANIP AMRN ALDX ATRA AXSM CRBP

| Held by: VTI SURI VXF IWC DFMC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.29	Insider Own	12.49%	Shs Outstand	53.23M	Perf Week	8.05%
Market Cap	185.81M	Forward P/E	-	EPS next Y	-0.98	Insider Trans	0.00%	Shs Float	46.59M	Perf Month	-20.32%
Enterprise Value	164.37M	PEG	-	EPS next Q	-0.30	Inst Own	46.17%	Short Float	15.28%	Perf Quarter	-36.20%
Income	-54.65M	P/S	-	EPS this Y	-5.94%	Inst Trans	7.36%	Short Ratio	10.95	Perf Half Y	1.16%
Sales	0.00M	P/B	8.63	EPS next Y	25.78%	ROA	-135.42%	Short Interest	7.12M	Perf YTD	-29.78%
Book/sh	0.40	P/C	5.10	EPS next 5Y	-	ROE	-257.67%	52W High	6.03 -42.07%	Perf Year	66.99%
Cash/sh	0.68	P/FCF	-	EPS past 3/5Y	32.06% 25.38%	ROIC	-167.08%	52W Low	1.95 78.97%	Perf 3Y	-50.85%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.73% 7.37%	Perf 5Y	-69.39%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-5.42%	Oper. Margin	-	ATR (14)	0.24	Perf 10Y	-99.78%
Dividend Ex-Date	-	Quick Ratio	4.39	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	47.89	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.39	EPS Q/Q	23.17%	SMA20	1.84%	Beta	2.06	Target Price	14.86
Payout	-	Debt/Eq	0.70	Sales Q/Q	-	SMA50	-11.90%	Rel Volume	0.87	Prev Close	3.32
Employees	28	LT Debt/Eq	0.52	Earnings	Mar 24 BMO	SMA200	-8.19%	Avg Volume	650.00K	Price	3.49
IPO	Oct 12, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.78% -	Trades		Volume	570,232	Change	5.12%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-25-25	Initiated	Citizens JMP	Mkt Outperform	$19
Aug-21-25	Initiated	H.C. Wainwright	Buy	$12
Nov-14-24	Initiated	Rodman & Renshaw	Buy	$12
Sep-27-24	Initiated	Raymond James	Strong Buy	$20
May-10-23	Reiterated	Maxim Group	Buy	$8 → $20
Jun-23-21	Initiated	Oppenheimer	Outperform	$23

Mar-26-26 08:30AM	Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability (GlobeNewswire)
Mar-25-26 08:30AM	Achieve Life Sciences, Inc. Q4 2025 Earnings Call Summary (Moby)
Mar-24-26 03:02PM	Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com) -28.40%
02:23PM	Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses (Newsfile)
07:00AM	Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates (GlobeNewswire)
08:30AM	Loading…
Mar-17-26 08:30AM	Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026 (GlobeNewswire)
Mar-04-26 08:00AM	Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study (GlobeNewswire) +5.77%
Feb-02-26 07:32PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (Insider Monkey)
Jan-30-26 04:05PM	Achieve Life Sciences Announced Granting of New Hire Inducement Awards (GlobeNewswire)
Jan-12-26 08:47AM	Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer (GlobeNewswire)
Dec-17-25 04:11PM	Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week (PR Newswire)
Dec-08-25 04:10PM	Achieve Life Sciences Announced Granting of New Hire Inducement Awards (GlobeNewswire)
Nov-25-25 08:40AM	FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation (Insider Monkey) +15.62%
Nov-06-25 04:01PM	Achieve Life Sciences Inc (ACHV) Q3 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
07:00AM	Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program (GlobeNewswire)
08:30AM	Loading…
Nov-03-25 08:30AM	Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation (GlobeNewswire)
Oct-29-25 08:30AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025 (GlobeNewswire)
Oct-22-25 03:31PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (Insider Monkey)
Oct-20-25 08:30AM	Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer (GlobeNewswire) +19.05%
08:25AM	FDA Grants First CNPV Vouchers, Igniting Rally in Biotech Stocks (GuruFocus.com)
Oct-17-25 04:21PM	The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. (Investor's Business Daily) +36.36%
07:30AM	Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation (GlobeNewswire)
Oct-02-25 04:01PM	Achieve Life Sciences Announces Granting of New Hire Inducement Awards (GlobeNewswire)
Sep-22-25 08:30AM	Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline's Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD (GlobeNewswire)
Sep-18-25 08:30AM	Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer (GlobeNewswire)
Sep-11-25 05:01PM	Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer (GlobeNewswire)
Sep-03-25 08:30AM	Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation (GlobeNewswire)
Sep-02-25 08:30AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +13.36%
Aug-21-25 02:11PM	Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years (Benzinga) +12.02%
07:30AM	Loading…
Aug-07-25 07:30AM	Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program (GlobeNewswire)
Jul-29-25 08:30AM	Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference (GlobeNewswire) -5.20%
Jul-24-25 08:30AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025 (GlobeNewswire)
Jul-13-25 06:15AM	Raymond James Predicts Up to ~760% Surge for These 2 Strong Buy Stocks (TipRanks)
Jul-07-25 08:56AM	Should You Hold Achieve Life Sciences (ACHV)? (Insider Monkey) -5.05%
Jul-06-25 04:00AM	Omnicom, Achieve Life Sciences Partner for AI-Driven Launch of New Nicotine Dependence Treatment (Insider Monkey)
Jun-30-25 07:52PM	Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities (GlobeNewswire)
Jun-26-25 11:43PM	Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering (GlobeNewswire) -7.63% -36.47%
04:03PM	Achieve Life Sciences Announces Proposed Underwritten Public Offering (GlobeNewswire)
04:02PM	Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades (GlobeNewswire)
04:01PM	Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation (GlobeNewswire)
May-28-25 08:30AM	Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-20-25 08:30AM	Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake (GlobeNewswire)
May-14-25 03:06AM	Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) -6.42%
01:56AM	Q1 2025 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-13-25 07:30AM	Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program (GlobeNewswire) +6.85%
May-06-25 08:30AM	Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 (GlobeNewswire) -6.25%
Apr-22-25 11:26AM	Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial (TipRanks) +10.22%
Apr-21-25 11:19AM	Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine (GlobeNewswire) +13.07%
Mar-20-25 06:25PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (InsiderMonkey)
Mar-12-25 03:14AM	Q4 2024 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents) -9.25%
03:02AM	Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
Mar-11-25 07:30AM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program (GlobeNewswire)
Mar-07-25 08:30AM	Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference (GlobeNewswire)
Mar-06-25 08:30AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 (GlobeNewswire) +9.03%
Feb-18-25 07:29AM	Here are Rogue Funds Updates on Achieve Life Sciences (ACHV) (Insider Monkey)
Feb-11-25 08:30AM	Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference (GlobeNewswire)
Feb-10-25 08:30AM	Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial (GlobeNewswire) +15.74%
Jan-24-25 12:14PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (Insider Monkey)
Jan-10-25 08:30AM	Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors (GlobeNewswire)
Jan-07-25 08:30AM	Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission (GlobeNewswire) +5.07%
Jan-06-25 08:30AM	Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week (GlobeNewswire)
Jan-02-25 11:04AM	Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1? (Insider Monkey)
Dec-09-24 08:30AM	Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer (GlobeNewswire)
Dec-03-24 08:30AM	Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA (GlobeNewswire)
Nov-14-24 08:30AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Nov-08-24 02:01PM	Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) -7.40%
Nov-07-24 04:05PM	Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Oct-24-24 08:00AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024 (GlobeNewswire)
Oct-23-24 08:00AM	Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting (GlobeNewswire)
Oct-16-24 08:00AM	Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline (GlobeNewswire)
Oct-10-24 08:00AM	Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting (GlobeNewswire)
Oct-01-24 08:45AM	Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs (GlobeNewswire)
Aug-26-24 04:30PM	Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors (GlobeNewswire)
Aug-13-24 04:01PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Jul-31-24 08:00AM	Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence (GlobeNewswire)
Jul-29-24 08:00AM	Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank (GlobeNewswire)
Jul-25-24 08:00AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024 (GlobeNewswire)
Jul-15-24 08:00AM	Milestone Pharmaceuticals Refreshes Board of Directors (GlobeNewswire)
Jul-09-24 08:00AM	Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024 (GlobeNewswire)
Jul-01-24 08:00AM	Achieve Life Sciences Announces Addition to the U.S. Russell 3000 and Russell Microcap Indexes (GlobeNewswire)
May-29-24 08:00AM	Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes (GlobeNewswire)
May-17-24 08:00AM	Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting (GlobeNewswire)
May-13-24 08:55AM	Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating (MT Newswires)
May-10-24 03:47PM	Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results (GuruFocus.com)
12:41PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 04:01PM	Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update (GlobeNewswire)
May-06-24 11:16AM	Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine (GlobeNewswire)
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 08:00AM	Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024 (GlobeNewswire)
Apr-11-24 08:00AM	Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference (GlobeNewswire)
Apr-01-24 03:30PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-29-24 06:24AM	Q4 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 08:53PM	ACHV Stock Earnings: Achieve Life Sciences Beats EPS for Q4 2023 (InvestorPlace)
05:32PM	Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval (GuruFocus.com)
04:01PM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update (GlobeNewswire)
Mar-20-24 08:00AM	Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire)
Mar-14-24 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024 (GlobeNewswire)
Mar-08-24 08:35AM	Life Science Virtual Investor Forum Presentations Now Available for Online Viewing (GlobeNewswire)
Mar-06-24 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Oki Mark K	Chief Financial Officer	Sep 18 '25	Option Exercise	0.00	168,000	0	178,000	Sep 22 04:31 PM
Oki Mark K	Chief Financial Officer	Sep 18 '25	Sale	2.92	50,060	146,175	127,940	Sep 22 04:31 PM
Stewart Richard Alistair	Chief Executive Officer	Sep 18 '25	Option Exercise	0.00	297,500	0	358,376	Sep 22 04:29 PM
Stewart Richard Alistair	Chief Executive Officer	Sep 18 '25	Sale	2.92	129,501	378,143	228,875	Sep 22 04:29 PM
Wan Jerry	Principal Accounting Officer	Sep 04 '25	Option Exercise	0.00	34,100	0	46,764	Sep 08 04:59 PM
Wan Jerry	Principal Accounting Officer	Sep 04 '25	Sale	2.77	14,070	38,974	32,694	Sep 08 04:59 PM
KING THOMAS BRAXTON	Director	Sep 04 '25	Option Exercise	0.00	455,000	0	455,000	Sep 08 04:54 PM
KING THOMAS BRAXTON	Director	Sep 04 '25	Sale	2.77	139,858	387,407	315,142	Sep 08 04:54 PM
JACOBS CINDY	President & CMO	Sep 04 '25	Option Exercise	0.00	110,000	0	143,214	Sep 08 04:51 PM
JACOBS CINDY	President & CMO	Sep 04 '25	Sale	2.77	27,629	76,532	115,585	Sep 08 04:51 PM
Xinos Jaime	Chief Commercial Officer	Sep 04 '25	Option Exercise	0.00	69,000	0	95,286	Sep 08 04:39 PM
Xinos Jaime	Chief Commercial Officer	Sep 04 '25	Sale	2.77	20,854	57,766	74,432	Sep 08 04:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACHV

Achieve Life Sciences Inc

Upgrade your Finviz experience